-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Inozyme Pharma, Inc. quarterly/annual Interest Expense history and growth rate from 2023 to 2024.
- Inozyme Pharma, Inc. Interest Expense for the quarter ending March 31, 2024 was $1.33 M, a 304% increase year-over-year.
- Inozyme Pharma, Inc. annual Interest Expense for 2023 was $3.33 M, a 1172% increase from 2022.
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)